Investors Snatch TCRR Even Cheaper Than Its Secondary Stock Offering
January 21, 2021 at 10:02 AM EST
Looking back to 2 days ago, TCR2 Therapeutics Inc (TCRR) priced a 4,590,164 share secondary stock offering at $30.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..